Publication:
ASEAN Vaccine Manufacturing Research Project: Philippines Country Case Study

Simple item page
dc.contributor.authorWorld Bank
dc.date.accessioned2023-09-20T20:21:40Z
dc.date.available2023-09-20T20:21:40Z
dc.date.issued2023-06-16
dc.description.abstractThe COVID-19 pandemic has had a devastating effect on the ASEAN region, which has recorded over 27 million cases of the virus. Despite rapid development of a range of COVID-19 vaccines using innovative technologies, access to these vaccines has been a challenge, with manufacturing mostly concentrated in the US and Europe for high-value mRNA vaccines, and China and India for traditional platforms and high-volume production. Countries with domestic COVID-19 vaccine manufacturing capacity prioritized domestic vaccine requirements over foreign needs, putting countries with limited production capabilities at a disadvantage. ASEAN countries, which overall have made limited investments in research and development of vaccines and biologicals, were highly dependent on imports, resulting in heightened vulnerability during COVID 19 surges. Despite the existence of an established framework for ASEAN coordination on vaccines, there has been minimal coordination between member states to collectively procure COVID-19 vaccines. Consequently, ASEAN countries have experienced a common set of challenges in navigating the complex global vaccine market to ramp up COVID-19 vaccination. Leaders of ASEAN member states have recognized the need for the region to be self-sufficient in vaccine research and manufacturing to effectively address future pandemics and build regional vaccine security. ASEAN must build regional capacity to develop, test efficacy, and scale up manufacture of vaccines, building on existing country-level strengths and avoiding duplication.en
dc.identifierhttp://documents.worldbank.org/curated/en/099061623000012058/P17809203b8c59008093090b94a46e3b835
dc.identifier.doi10.1596/40376
dc.identifier.urihttps://openknowledge.worldbank.org/handle/10986/40376
dc.languageEnglish
dc.language.isoen_US
dc.publisherWashington, DC: World Bank
dc.rightsCC BY-NC 3.0 IGO
dc.rights.holderWorld Bank
dc.rights.urihttps://creativecommons.org/licenses/by-nc/3.0/igo
dc.subjectCOVID-19
dc.subjectVACCINE
dc.subjectASEAN REGION
dc.titleASEAN Vaccine Manufacturing Research Projecten
dc.title.subtitlePhilippines Country Case Studyen
dc.typeReport
dspace.entity.typePublication
okr.crossref.titleASEAN Vaccine Manufacturing Research Project: Philippines Country Case Study
okr.date.disclosure2023-06-16
okr.date.lastmodified2023-06-15T00:00:00Zen
okr.doctypeEconomic & Sector Work
okr.doctypeEconomic & Sector Work::Other Health Study
okr.docurlhttp://documents.worldbank.org/curated/en/099061623000012058/P17809203b8c59008093090b94a46e3b835
okr.guid099061623000012058
okr.identifier.docmidP178092-3b8c5937-962a-4b08-9309-b94a46e3b835
okr.identifier.doihttp://dx.doi.org/10.1596/40376
okr.identifier.externaldocumentum34094652
okr.identifier.internaldocumentum34094652
okr.identifier.report182881
okr.import.id1830
okr.importedtrueen
okr.language.supporteden
okr.pdfurlhttp://documents.worldbank.org/curated/en/099061623000012058/pdf/P17809203b8c59008093090b94a46e3b835.pdfen
okr.region.administrativeEast Asia and Pacific
okr.region.countryPhilippines
okr.sectorHealth-HG
okr.themeHealth Systems and Policies,Human Development and Gender,Health Finance,Disease Control,Health System Strengthening,Pandemic Response
okr.topicHealth, Nutrition and Population::Immunizations
okr.unitHealth Nutrition &Population EAP (HEAHN)
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
P17809203b8c59008093090b94a46e3b835.pdf
Size:
2.25 MB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
P17809203b8c59008093090b94a46e3b835.txt
Size:
93.29 KB
Format:
Plain Text
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
Other Health Study